Patterns of Pulmonary Function in Patients Undergoing Spirometry at a Tertiary Referral Hospital in West Java, Indonesia

Muhammad Rizky Wisesa, Iceu Dimas Kulsum, Prayudi Santoso

Abstract


Spirometry is a fundamental tool for assessing pulmonary function, as it provides critical insights into respiratory health. This study aimed to explore pulmonary function abnormalities among patients undergoing spirometry at Dr. Hasan Sadikin General Hospital, Bandung, Indonesia. Conducted in May 2024 with 206 participants, the study employed a descriptive, observational design. The average patient age was 45.86 years, with a majority being female (64.1%) and unemployed (62.1%). Comorbidities were present in 25.67% of patients, with hypertension being the most common (50.87%). The primary indications for spirometry in this hospital were preoperative risk assessment (75.2%) and evaluation following treatment for multidrug-resistant tuberculosis. The study demonstrated that 67.5% of patients had restrictive lung disorders, 31.6% had normal lung function, and 1% had obstructive patterns. Restrictive lung disorders were more prevalent in older adults and females, with most cases being mild (64.0%). These findings underscore the necessity of spirometry in preoperative assessments, and highlights the dominance of restrictive lung disorders in the hospital’s patient population. Future research should incorporate larger sample sizes, longer study durations, and add additional variables such as respiratory risk factors to enhance understanding of pulmonary function trends in this setting.

Keywords


Comorbidity, pulmonary disease, spirometry, tertiary care centers

Full Text:

PDF

References


  1. Bourke SJ, Burns GP, Macfarlane JG. Respiratory medicine. 10th ed. Oxford: Wiley Blackwell; 2022.
  2. Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200(8):e70-e88. doi:10.1164/rccm.201908-1590ST
  3. Stanojevic S, Kaminsky DA, Miller MR, Thompson B, Aliverti A, Barjaktarevic I, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022;60(1):2101499. doi:10.1183/13993003.01499-2021
  4. O’Reilly S. Chronic obstructive pulmonary disease. Am J Lifestyle Med. 2017;11(4):296.
  5. Firdausi NL, Artanti KD, Li CY. Analysis of risk factors affecting the occurrence of chronic obstructive pulmonary disease in Indonesia. J Berk Epidemiol. 2021;9(1):18.
  6. Djajalaksana S, Listyoko AS, Magdalena, Muhammad I, Dini Z, Primaputri CC. Chronic obstructive pulmonary disease knowledge analysis in high school students. Kemas. 2023;18(3):356–64.
  7. Mboi N, Syailendrawati R, Ostroff SM, Elyazar IR, Glenn SD, Rachmawati T, et al. The state of health in Indonesia’s provinces, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Glob Health. 2022;10(11):e1632–45. doi:10.1016/S2214-109X(22)00371-0
  8. Weinberger SE, Cockrill BA, Mandel J. Principles of pulmonary medicine. 7th ed. Philadelphia: Elsevier; 2019. p. 52–61.
  9. Ramalho SHR, Shah AM. Lung function and cardiovascular disease: a link. Trends Cardiovasc Med. 2021;31(2):93–8. doi:10.1016/j.tcm.2019.12.009
  10. Sugiyono. Metodelogi penelitian kuantitatif dan kualitatif dan R&D. Bandung: Alfabeta; 2019.
  11. Agustí A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P, et al. Global Initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Eur Respir J. 2023;61(4):2300239. doi:10.1183/13993003.00239-2023
  12. Kim J, Lee CH, Lee HY, Kim H. Association between comorbidities and preserved ratio impaired spirometry: using the Korean National Health and Nutrition Examination Survey IV–VI. Respiration. 2022;101(1):25–33. doi:10.1159/000517599
  13. Khan B, Naeem A, Nizamuddin, Naim F, Azam K, Rehman A. Pulmonary function testing patterns in patients recovering from COVID-19: a prospective observational study. Prof Med J. 2025;32(1):5–10.
  14. Ratnakumar S, Denneny EK, Evans R, Gotowiec M, Zhu J, Porter JC, et al. Post-pulmonary tuberculosis lung function: a systematic review and meta-analysis. Lancet Glob Health. 2025;13(6):e1020–9. doi:10.1016/S2214-109X(25)00105-6
  15. Esposito DB, Lanes S, Donneyong M, Holick CN, Lasky JA, Lederer D, et al. Idiopathic pulmonary fibrosis in United States automated claims: incidence, prevalence, and algorithm validation. Am J Respir Crit Care Med. 2015;192(10):1200–7. doi:10.1164/rccm.201504-0818OC
  16. Santos NCD, Miravitlles M, Camelier AA, Almeida VDC, Maciel RRBT, Camelier FWR. Prevalence and impact of comorbidities in individuals with chronic obstructive pulmonary disease: a systematic review. Tuberc Respir Dis (Seoul). 2022;85(3):205–220. doi:10.4046/trd.2021.0179




DOI: https://doi.org/10.15395/mkb.v58.4129

Article Metrics

Abstract view : 11 times
PDF - 10 times

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


 


Creative Commons License
MKB is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

 


View My Stats